Fetuin B Is a Secreted Hepatocyte Factor Linking Steatosis to Impaired Glucose Metabolism.
暂无分享,去创建一个
Robert J A Goode | M. Febbraio | B. Kingwell | M. Molloy | S. Rensen | G. Lancaster | J. Greve | M. Watt | R. Meex | J. Lo | A. Hoy | Alexander J. Morris | Russell D. Brown | M. Burke | M. Kraakman | C. Bruce | R. Goode | Ruth C. R. Meex
[1] Raphael Gottardo,et al. Orchestrating high-throughput genomic analysis with Bioconductor , 2015, Nature Methods.
[2] M. Febbraio,et al. The Dual-Specificity Phosphatase 2 (DUSP2) Does Not Regulate Obesity-Associated Inflammation or Insulin Resistance in Mice , 2014, PloS one.
[3] Z. Andrews,et al. Hypothalamic Neurogenesis Is Not Required for the Improved Insulin Sensitivity Following Exercise Training , 2014, Diabetes.
[4] P. Meikle,et al. PLIN5 deletion remodels intracellular lipid composition and causes insulin resistance in muscle , 2014, Molecular metabolism.
[5] F. Schick,et al. Relationships of body composition and liver fat content with insulin resistance in obesity‐matched adolescents and adults , 2014, Obesity.
[6] R. Bergman,et al. FGF19 action in the brain induces insulin-independent glucose lowering. , 2013, The Journal of clinical investigation.
[7] R. Schekman,et al. Unconventional Secretion, Unconventional Solutions , 2013, Science.
[8] P. Meikle,et al. Distinct patterns of tissue-specific lipid accumulation during the induction of insulin resistance in mice by high-fat feeding , 2013, Diabetologia.
[9] N. Stefan,et al. Circulating fetuin-A and free fatty acids interact to predict insulin resistance in humans , 2013, Nature Medicine.
[10] N. Stefan,et al. The role of hepatokines in metabolism , 2013, Nature Reviews Endocrinology.
[11] P. Meikle,et al. Ceramides Contained in LDL Are Elevated in Type 2 Diabetes and Promote Inflammation and Skeletal Muscle Insulin Resistance , 2013, Diabetes.
[12] H. Ressom,et al. iTRAQ-based quantitative protein expression profiling and MRM verification of markers in type 2 diabetes. , 2012, Journal of proteome research.
[13] N. Danial,et al. Polysome Profiling in Liver Identifies Dynamic Regulation of Endoplasmic Reticulum Translatome by Obesity and Fasting , 2012, PLoS genetics.
[14] S. Mukhopadhyay,et al. Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance , 2012, Nature Medicine.
[15] Juan Antonio Vizcaíno,et al. Improvements in the protein identifier cross-reference service , 2012, Nucleic Acids Res..
[16] L. Ryner,et al. Metabolic Consequences of Hepatic Steatosis in Overweight and Obese Adolescents , 2012, Diabetes Care.
[17] G. Shulman,et al. Mechanisms for Insulin Resistance: Common Threads and Missing Links , 2012, Cell.
[18] R. Bergman,et al. Simultaneous measurement of insulin sensitivity, insulin secretion and the disposition index in conscious unhandled mice , 2012, Obesity.
[19] Brian J. Bennett,et al. Comparative Analysis of Proteome and Transcriptome Variation in Mouse , 2011, PLoS genetics.
[20] E. Ravussin,et al. Intrahepatic and intramyocellular lipids are determinants of insulin resistance in prepubertal children , 2011, Diabetologia.
[21] J. Yun,et al. Plasma proteome analysis in diet‐induced obesity‐prone and obesity‐resistant rats , 2010, Proteomics.
[22] M. Honda,et al. A liver-derived secretory protein, selenoprotein P, causes insulin resistance. , 2010, Cell metabolism.
[23] Yun-ping Zhu,et al. Functional proteomic analysis of nonalcoholic fatty liver disease in rat models: Enoyl–coenzyme a hydratase down‐regulation exacerbates hepatic steatosis , 2010, Hepatology.
[24] B. S. Mohammed,et al. Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity , 2009, Proceedings of the National Academy of Sciences.
[25] D. James,et al. Pigment epithelium-derived factor contributes to insulin resistance in obesity. , 2009, Cell metabolism.
[26] D. Ribnicky,et al. Failure of dietary quercetin to alter the temporal progression of insulin resistance among tissues of C57BL/6J mice during the development of diet-induced obesity , 2009, Diabetologia.
[27] R. Kesterson,et al. Identification of adropin as a secreted factor linking dietary macronutrient intake with energy homeostasis and lipid metabolism. , 2008, Cell metabolism.
[28] R. DeFronzo,et al. Strong association between insulin resistance in liver and skeletal muscle in non‐diabetic subjects , 2008, Diabetic medicine : a journal of the British Diabetic Association.
[29] Pan Du,et al. lumi: a pipeline for processing Illumina microarray , 2008, Bioinform..
[30] Xiaomin Song,et al. iTRAQ experimental design for plasma biomarker discovery. , 2008, Journal of proteome research.
[31] B. S. Mohammed,et al. Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects. , 2008, Gastroenterology.
[32] D. Greco,et al. Gene expression in human NAFLD. , 2008, American journal of physiology. Gastrointestinal and liver physiology.
[33] Deepak Kolippakkam,et al. Comprehensive and quantitative proteome profiling of the mouse liver and plasma , 2008, Hepatology.
[34] C. Bogardus,et al. Increased fat accumulation in liver may link insulin resistance with subcutaneous abdominal adipocyte enlargement, visceral adiposity, and hypoadiponectinemia in obese individuals. , 2008, The American journal of clinical nutrition.
[35] K. Strissel,et al. Adipocyte Death, Adipose Tissue Remodeling, and Obesity Complications , 2007, Diabetes.
[36] J. K. Nicholson,et al. Subtle metabolic and liver gene transcriptional changes underlie diet-induced fatty liver susceptibility in insulin-resistant mice , 2007, Diabetologia.
[37] F. Schick,et al. α2-Heremans-Schmid Glycoprotein/ Fetuin-A Is Associated With Insulin Resistance and Fat Accumulation in the Liver in Humans , 2006 .
[38] H. Koyama,et al. Association of serum fetuin-A with insulin resistance in type 2 diabetic and nondiabetic subjects. , 2006, Diabetes care.
[39] A. Baranova,et al. A genomic and proteomic study of the spectrum of nonalcoholic fatty liver disease , 2005, Hepatology.
[40] M. Hawkins,et al. The regulation of glucose effectiveness: how glucose modulates its own production , 2005, Current opinion in clinical nutrition and metabolic care.
[41] J. Gromada,et al. FGF-21 as a novel metabolic regulator. , 2005, The Journal of clinical investigation.
[42] T. Suda,et al. Angiopoietin-related growth factor antagonizes obesity and insulin resistance , 2005, Nature Medicine.
[43] K. Petersen,et al. Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes. , 2005, Diabetes.
[44] Jonathan C. Cohen,et al. Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity , 2004, Hepatology.
[45] Jean-Charles Sanchez,et al. Effect of high‐fat diet on the expression of proteins in muscle, adipose tissues, and liver of C57BL/6 mice , 2004, Proteomics.
[46] J. George,et al. Non‐alcoholic steatohepatitis in the Asia–Pacific region: Future shock? , 2004, Journal of gastroenterology and hepatology.
[47] L. Tartaglia,et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. , 2003, The Journal of clinical investigation.
[48] W. Jahnen-Dechent,et al. Tissue distribution and activity testing suggest a similar but not identical function of fetuin-B and fetuin-A. , 2003, The Biochemical journal.
[49] G. Pacini,et al. Insufficient islet compensation to insulin resistance vs. reduced glucose effectiveness in glucose-intolerant mice. , 2002, American journal of physiology. Endocrinology and metabolism.
[50] G. Grunberger,et al. Improved insulin sensitivity and resistance to weight gain in mice null for the Ahsg gene. , 2002, Diabetes.
[51] Y. Higaki,et al. Effect of mild exercise training on glucose effectiveness in healthy men. , 2001, Diabetes care.
[52] G. Brandi,et al. Prevalence of and Risk Factors for Hepatic Steatosis in Northern Italy , 2000, Annals of Internal Medicine.
[53] B. Neuschwander‐Tetri,et al. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions , 1999, American Journal of Gastroenterology.
[54] H. Shamoon,et al. Regulation of endogenous glucose production by glucose per se is impaired in type 2 diabetes mellitus. , 1998, The Journal of clinical investigation.
[55] C. Day,et al. Steatohepatitis: a tale of two "hits"? , 1998, Gastroenterology.
[56] R N Bergman,et al. Role of Glucose Effectiveness in the Determination of Glucose Tolerance , 1996, Diabetes Care.
[57] E. Kraegen,et al. Development of Muscle Insulin Resistance After Liver Insulin Resistance in High-Fat–Fed Rats , 1991, Diabetes.
[58] Matt Cave,et al. Integrated hepatic transcriptome and proteome analysis of mice with high-fat diet-induced nonalcoholic fatty liver disease. , 2011, The Journal of nutritional biochemistry.
[59] M. Watt,et al. Adipose triacylglycerol lipase is a major regulator of hepatic lipid metabolism but not insulin sensitivity in mice , 2010, Diabetologia.
[60] S. Schinner,et al. Adipocyte Death, Adipose Tissue Remodeling, and Obesity Complications , 2009 .